Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medifico eyes Dow Chemical as pathway to global expansion

This article was originally published in Clinica

Executive Summary

Medical equipment financing firm Medifico (Lancaster, Pennsylvania) is looking to take its Brainvue-TCD blood flow measurement systems to the “fastest-growing middle-class markets in emerging countries” after entering talks with the healthcare and wellness division of the Dow Chemical Company. The Brainvue-TCD, which was developed by Yonkers, New York-based Multigon Industries, is an ultrasound solution for the noninvasive measurement of the velocity of blood flow in the brain, and is designed to aid in the diagnosis of strokes, sickle cell disease, patent foramen ovale and other neurological disorders. Financial details of the deal were not revealed.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT042015

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel